Amgen’s Post

The Gothenburg region excels in life science innovation. The recent investment from #ThermoFisherScientific proves it. In late 2025, the Fortune 500 giant will open its bioanalytical laboratory at GoCo Health Innovation City, next to AstraZeneca's R&D site. This state-of-the-art facility will cover 2,700 square meters and create 140 new jobs, from research roles to managerial positions. Thermo Fisher's entrance represents a significant advancement in bioanalysis, providing support to pharmaceutical and biotechnology clients through a range of services. The region has a rich history in medicine, having developed the world's first effective drinkable cholera vaccine and this legacy is a strong foundation for ongoing innovation. "This expansion reflects our commitment to delivering precise, timely data for informed decision-making," says Leon Wyszkowski, president of analytical services at Thermo Fisher. I'm glad that such big companies are noticing the Gothenburg region. With such a dedicated focus, the region's growth in the life sciences space seems unstoppable. Have you worked with a company in Gothenburg's life science sector? Share your story in the comments below! #Innovation #DrugDevelopment #Pharma #Sweden

Sweden's dynamic ecosystem for biopharma innovation and manufacturing positions the country as a global leader in this sector. Cytiva's significant presence in Sweden exemplifies how the industry leverages this robust ecosystem to effectively serve biopharma customers worldwide.
 Cytiva #Danaher #Biomanufacturing #SwedenBIO

🗞 𝟗 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐭𝐡𝐞 𝐰𝐚𝐲 𝐢𝐧 𝐃𝐞𝐧𝐦𝐚𝐫𝐤 "Known for being one of the happiest countries in the world, #Denmark has become a big hub for biotech in #Europe. In the last few years, Denmark’s life sciences sector has accelerated its output of high-quality research, as the country was ranked 16th overall for biological sciences-related output in 2022. ✅ The country is also among the fastest-growing nations in Europe for biotech #investment, hitting $𝟒𝟑𝟒 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟏. Following the example of Danish pharma giant Novo Nordisk – which on its own has helped to raise Denmark’s gross domestic product (GDP) after the success of its weight loss drug, #Wegovy – many biotech companies in Denmark are striving to bring forth the next big breakthrough in the biopharma industry. " 👉 Full article: https://lnkd.in/d_cqB-_P Source: Labiotech.eu Acesion Pharma Adcendo Ascendis Pharma Bavarian Nordic Genmab Hoba Therapeutics IO Biotech Minervax ApS Zealand Pharma Danish Life Science Cluster #biotech #investment #medicines #europe #funding #lifesciences #biopharma #danishlifescience

Dive into Australia’s biotech ecosystem at #BIOHK2024! Get ready for insights and engaging discussions with members of the Australian Biotech Mission 2024. Join us to successfully start your next clinical trial with our #australianadvantage! Taking place between September 11-14, this year's event will feature discussions on cutting-edge biotech developments, raise awareness of innovative research and products, and inspire interaction and engagement to foster new collaborations. For 360biolabs, this event provides us with another valuable opportunity to promote the advantages of the Australian life sciences ecosystem, with our partners in our mission Acclime, Adjutor Healthcare Group, Alithia Life Sciences, Nucleus Network, SYNthesis BioVentures and TrialKey, sponsored by APAC Financial Services. You can find us at Booth # A1-2, E1-2, located at Hall 3DE within the Convention Centre. If you’re attending BIOHK2024 and want to discover how we can support your biopharmaceutical goals, let’s meet!  Connect with Angela Luttick, Sharon S., and Han Li, reach out to us at bd@360biolabs.com, message us on the partnering platform, or here on LinkedIn to schedule a one-on-one meeting.    Looking forward to engaging with you and exploring new opportunities together!    #360biolabs #bioanalyticallab #theaustralianadvantage #BIOHK #AustralianDelegation #BioTechOpportunities #biotechnology #lifesciences

Discussion to the Pilot industry Biotechnology at this year’s conference of the House of Pharma and Healthcare On September 2 and 3, the 13th annual meeting of the “House of Pharma and Healthcare” took place on the Westend campus of Goethe-Universität Frankfurt. The general conditions and developments in the pharmaceutical and biotechnology sector were examined in plenary sessions and parallel workshops. Claudia Englbrecht from BIO Deutschland e. V. Deutschland moderated a panel discussion entitled “Biotechnology - New Leading Industry in Germany.” The panelists were Sylvia Wojczewski, Ph.D. (CEO Biospring GmbH and board member of BIO Deutschland), Prof. Helga Rübsamen-Schaeff (AiCuris, co-head of the BIO Deutschland health policy working group), Prof. Dr. Jochen Maas (Vice President of the House of Pharma) and Rainer Waldschmidt (Managing Director of the Hessen Agentur). The discussion showed that the pharmaceutical and biotech industries are important drivers and growth engines of the industrial healthcare sector with great potential to push the industry location Germany into the forefront. However, it also became clear that there are locational disadvantages for German companies in international competition. For example, Contract Development and Manufacturing Organizations (CDMOs) such as Biospring are subject to higher corporate taxes than in comparable countries. The challenge of obtaining sufficient growth capital for the growth phase and excessive bureaucracy were also topics of discussion.

Spotlight on #Pharma #Partnerships in #TechBio: Showcasing Roche In the rapidly evolving landscape of biotechnology, strategic partnerships are the key to driving innovation and achieving groundbreaking advancements. Roche, a global leader in pharmaceuticals and diagnostics, exemplifies this collaborative spirit. 🌐 Roche's TechBio Collaborations Of 168 disclosed partnerships worldwide, Roche has forged 44 impactful alliances in the TechBio sector. These collaborations span the globe, reflecting Roche's commitment to leveraging diverse expertise and cutting-edge technology to address unmet medical needs. 📊 Geographic Distribution of Roche's TechBio Partnerships: - 51% with US ventures - 24% with Asia-Pacific ventures - 24% with European ventures This strategic distribution underscores Roche's focus on harnessing regional strengths and fostering innovation hubs across major biotech regions. 🔬 Venture Maturity Insight: The average alpha score, indicating the maturity of Roche's TechBio portfolio, stands at an impressive 68.9. This metric highlights the advanced development stage and the ventures' robust potential within Roche's partnership ecosystem. #drugdiscovery #omics #bioinformatics

PLG is sponsoring an unmissable Biotech Panel Discussion at LSX BioPharm America on September 11 from 12:00 to 12:40 ET. Join industry leaders as they discuss why CMC development, often overlooked, is the decisive factor that can make or break Biotech Startups and their integration strategies. #Biotech #biopharmamerica #pharma #innovation #productdevelopment #healthcare #lifescience #cmc

The two week countdown is on for the World Companion Diagnostics and Liquid Biopsy Summit APAC!⏰ Here's (just) 164 reasons why you can't afford to miss out: 🟢 100+ precision medicine specialists from 10 countries including Singapore, China, Japan, Taiwan, Hong Kong, Malaysia, Australia, South Korea, USA, and the UK 🟢 38+ companies and academic institutes in attendance allowing you to network with key stakeholders from Abbvie, Amgen, Engine Biosciences, Johnson & Johnson, Takeda, and more 🟢 17 data driven case studies from leading pharma, biotech, academics and diagnostic companies giving detailed insights into how they are overcoming key challenges to deliver precision therapies to patients in need 🟢 6+ hours of networking including a dedicated speed networking session and a drinks reception at the end of day one 🟢 3 discussion led sessions where you can ask questions to our speakers, and join the conversation yourself With complimentary* passes available for drug developers and researchers, register your place here: https://ter.li/ph9rot *subject to terms and conditions - visit the website to learn more: https://ter.li/ph9rot #CDx #CompanionDiagnostics #PrecisionMedicine #Biomarkers #LiquidBiopsy

The Life Sciences Center (LSC) had the honor of hosting a delegation from Taiwan's Industrial Technology Research Institute (ITRI), led by the head of its Biopharmaceutical Unit, alongside LithuaniaBIO president Tomas Andrejauskas. Dr Vytautas Smirnovas, Director of the Institute of Biotechnology, welcomed the guests and presented LSC’s core activities and achievements, sparking insightful discussions about future synergies. The visit continued with a tour of LSC’s state-of-the-art laboratories, where Dr Giedrius Sasnauskas shared his groundbreaking research and emphasized potential areas for collaboration. This meeting underscored the importance of global partnerships in advancing biopharmaceutical research and innovation. #VilniusUniversity #LifeSciencesCenter #Biotechnology #ResearchCollaboration #GlobalPartnerships #Taiwan #Lithuania #CollaborationMatters